Screener
NeoGenomics NEO Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from NeoGenomics’s reported figures.
Based on trailing twelve months.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
FAQ
- What is NeoGenomics's return on equity?
- NeoGenomics (NEO) reported return on equity of -6.3% in Q2 2026.
- How has NeoGenomics's return on equity changed year-over-year?
- NeoGenomics's return on equity increased by 46.2% year-over-year, from -11.8% to -6.3%.
- What is the long-term trend for NeoGenomics's return on equity?
- Over 5 years (2020 to 2025), NeoGenomics's return on equity has grown at a 78.1% compound annual growth rate (CAGR), from 0.7% to -12.4%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about NeoGenomics's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude